<DOC>
	<DOC>NCT01280149</DOC>
	<brief_summary>The purpose of this study is to determine whether a neuropeptide, substance P, when injected along with an allergen, such as ragweed, can reduce allergic reactivity.</brief_summary>
	<brief_title>Reduction of IgE Antibody in Human Allergic Subjects</brief_title>
	<detailed_description>Allergic Rhinitis (Hay fever) affects many children and adults and is a risk factor for development of asthma. This study utilizes the neurotransmitter, substance P, a small molecule which is present in nerve endings, the brain, skin, lungs and the gastrointestinal tract. Subjects will receive substance P and a low dosage of an allergen, such as ragweed in an attempt to reduce allergic reactivity.</detailed_description>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Substance P</mesh_term>
	<mesh_term>Neurokinin A</mesh_term>
	<criteria>positive immediate type skin test to ragweed or grass pollen or a third (standardized) allergen if both ragweed and grass pollen allergen are not positive volunteers should be available for allergen injections and then cutaneous titrations for approximately 1 year from the start of the enrollment period volunteer is pregnant or lactating abnormal electrocardiogram for subjects over 50 years of age use of beta adrenergic antagonists or tricyclic antidepressants</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>substance P</keyword>
	<keyword>allergic rhinitis</keyword>
	<keyword>allergen immunotherapy</keyword>
</DOC>